| __timestamp | Madrigal Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 4042025 |
| Thursday, January 1, 2015 | 13392000 | 5279557 |
| Friday, January 1, 2016 | 9290000 | 8073913 |
| Sunday, January 1, 2017 | 7672000 | 44864073 |
| Monday, January 1, 2018 | 15293000 | 53488904 |
| Tuesday, January 1, 2019 | 22648000 | 65896361 |
| Wednesday, January 1, 2020 | 21864000 | 69968267 |
| Friday, January 1, 2021 | 37318000 | 92047281 |
| Saturday, January 1, 2022 | 48130000 | 131819000 |
| Sunday, January 1, 2023 | 108146000 | 87501000 |
Unleashing the power of data
In the dynamic world of biopharmaceuticals, understanding spending patterns can offer valuable insights into a company's strategic priorities. Over the past decade, Pharming Group N.V. and Madrigal Pharmaceuticals, Inc. have demonstrated contrasting approaches in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Pharming Group N.V. consistently increased its SG&A spending, peaking in 2022 with a 1,318% increase from its 2014 levels. This suggests a robust investment in administrative capabilities and market expansion. In contrast, Madrigal Pharmaceuticals, Inc. exhibited a more volatile pattern, with a dramatic surge in 2023, marking a 587% rise from 2014. This spike could indicate a strategic pivot or a response to market opportunities.
These spending trends reflect each company's unique strategy in navigating the competitive biopharma landscape, offering a glimpse into their future trajectories.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Pharming Group N.V.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Pharming Group N.V.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Opthea Limited
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?